← Leaderboards
Tracy E Crane
University Of Arizona
$4,495,176
Attributed
$10,968,850
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,968,850 · 4
By mechanism
R01$5,726,180 · 2
U01$4,851,495 · 1
R21$391,175 · 1
Top collaborators
- Melinda L Irwin4 shared
- Terry A Badger3 shared
- Christina Dieli-Conwright3 shared
- Jennifer A. Ligibel3 shared
- Alla Sikorskii3 shared
- Steven Bethard2 shared
- Rebecca Sharp1 shared
Most similar at University Of Arizona
Same institution · by research overlap
- James Marshall$14,878,530
- Scott J Leischow$11,598,102
- Halimatou Alaofe$590,904
- Katri Vanamo Typpo$2,724,187
- Iman A Hakim$2,077,132
Others in their field
Other Emerging Leaders on “Randomized”
- Beth Baseler · Leidos Biomedical Research, Inc.$194,920,310
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$36,614,885
- Abraham Aizer Brody · New York University School Of Medicine$23,359,458
- Yunda Huang · Fred Hutchinson Cancer Center$19,033,873
Research focus
RandomizedReportingAttentional ControlMental DepressionToxic EffectFatigueDietMalignant NeoplasmsCancer SurvivorLifestyle InterventionPhysical ActivityPatient Outcomes AssessmentsWomen&AposBiological MarkersExerciseDiet And ExerciseExercise InterventionGastrointestinalMalignant Breast NeoplasmEnrollmentChemotherapyDoseHomeAttenuated
Grant awards (12)
Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)$2,233,701
R01 · FY2025 · CA · contact PI
Trial of Exercise and Lifestyle (TEAL) in Women with Ovarian Cancer$1,288,540
U01 · FY2025 · CA
Managing symptoms and psychological distress during oral anti-cancer treatment$645,804
R01 · FY2025 · CA
Trial of Exercise and Lifestyle (TEAL) in Women with Ovarian Cancer$1,138,226
U01 · FY2024 · CA
Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)$732,901
R01 · FY2024 · CA · contact PI
Managing symptoms and psychological distress during oral anti-cancer treatment$613,476
R01 · FY2024 · CA
Trial of Exercise and Lifestyle (TEAL) in Women with Ovarian Cancer$1,175,632
U01 · FY2023 · CA
Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)$810,559
R01 · FY2023 · CA · contact PI
Managing symptoms and psychological distress during oral anti-cancer treatment$689,739
R01 · FY2023 · CA
Trial of Exercise and Lifestyle (TEAL) in Women with Ovarian Cancer$1,249,097
U01 · FY2022 · CA
Using natural language processing to determine predictors of healthy diet and physical activity behavior change in ovarian cancer survivors$181,863
R21 · FY2022 · CA · contact PI
Using natural language processing to determine predictors of healthy diet and physical activity behavior change in ovarian cancer survivors$209,312
R21 · FY2021 · CA · contact PI